These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7014053)

  • 1. Mineralocorticoids in the nephrotic syndrome of children.
    Ammenti A; Müller-Wiefel DE; Schärer K; Vecsei P
    Clin Nephrol; 1980 Nov; 14(5):238-45. PubMed ID: 7014053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal regulation of water metabolism in children with nephrotic syndrome.
    Rascher W; Tulassay T
    Kidney Int Suppl; 1987 Aug; 21():S83-9. PubMed ID: 3306110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
    Lan NC; Matulich DT; Stockigt JR; Biglieri EG; New MI; Winter JS; McKenzie JK; Baxter JD
    Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adrenocorticotropin on desoxycorticosterone, corticosterone and aldosterone excretion.
    Biglieri EG; Shambelan M; Slaton PE
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1090-101. PubMed ID: 4308415
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma mineralocorticoids, plasma renin, and urinary kallikrein in salt-sensitive and salt-resistant rats.
    Rapp JP; Tan SY; Margolius HS
    Endocr Res Commun; 1978; 5(1):35-41. PubMed ID: 710365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of edema formation in the nephrotic syndrome.
    Donckerwolcke RA; Vande Walle JG
    Kidney Int Suppl; 1997 Mar; 58():S72-4. PubMed ID: 9067949
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
    Bistrup C; Thiesson HC; Jensen BL; Skøtt O
    Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the level of production of cortisol, corticosterone, aldosterone and deoxycorticosterone in 4 cases of congenital adrenal hyperplasia due to II beta-hydroxylase deficiency.
    Loras B; Dazord A; Roux H; Bertrand J
    Rev Eur Etud Clin Biol; 1971; 16(6):585-90. PubMed ID: 5125107
    [No Abstract]   [Full Text] [Related]  

  • 12. Distal nephron sodium-potassium exchange in children with nephrotic syndrome.
    Donckerwolcke RA; France A; Raes A; Vande Walle J
    Clin Nephrol; 2003 Apr; 59(4):259-66. PubMed ID: 12708565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategy for studying mineralocorticoids other than aldosterone in arterial hypertension of hormonal origin].
    Roger M; Nahoul K; Laloy E; Scholler R
    Ann Med Interne (Paris); 1983; 134(3):238-41. PubMed ID: 6625419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in normal subjects.
    Grandchamp A; Scherrer JR; Veyrat R; Muller AF
    Helv Med Acta; 1969 Jan; 34(5):367-85. PubMed ID: 5766168
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior.
    Hlavacova N; Jezova D
    Horm Behav; 2008 Jun; 54(1):90-7. PubMed ID: 18377905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary free 18-hydroxycorticosterone, plasma aldosterone, and urinary aldosterone metabolites in normal pregnancy.
    Bauknecht H; Vecsei P; Endres H; Hettenbach A
    Am J Obstet Gynecol; 1982 Sep; 144(1):28-34. PubMed ID: 7114109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-renin hypertension and inherited mineralocorticoid diseases].
    Kastelan D; Giljević Z; Perković Z; Plavsić V; Breskovac L; Aganović I; Korsić M
    Lijec Vjesn; 1999; 121(7-8):245-9. PubMed ID: 10573960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sodium during formation of edema in children with nephrotic syndrome.
    Gurgoze MK; Gunduz Z; Poyrazoglu MH; Dursun I; Uzum K; Dusunsel R
    Pediatr Int; 2011 Feb; 53(1):50-6. PubMed ID: 20573038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.